Professor of Psychiatry, UNSW & Black Dog Institute, UNSW Sydney
Colleen Loo is a psychiatrist and clinical academic researcher of the University of New South Wales, based at the Black Dog Institute. She is an active clinician and researcher, and has had a role in developing and improving treatments for severe depression : electroconvulsive therapy (ECT) and novel treatments for mood disorders, including Transcranial Magnetic Stimulation (TMS), transcranial Direct Current Stimulation (tDCS) and ketamine. She established the first randomised controlled trials of TMS, tDCS and ketamine in psychiatry in Australia. Her research program now also includes studies of psychedelic-assisted therapy. She has been active in establishing clinical practice guidelines and policy to facilitate the translation of new treatments into clinical practice. Her team of researchers also studies the use of brain stimulation to enhance cognitive functioning (in mood disorders and healthy ageing), and to treat disorders.
Many people in Australia, including psychiatrists, were surprised when earlier this year the medicines regulator down-scheduled MDMA, known colloquially as ecstasy, and psilocybin, from magic mushrooms.
Many people in Australia, including psychiatrists, were surprised when earlier this year the medicines regulator down-scheduled MDMA, known colloquially as ecstasy, and psilocybin, from magic mushrooms.
Cardiologist; Director of the Heart Failure Unit and Department of Cardiac Rehabilitation, Concord Hospital
We invite you to our first webcast of 2026, where Prof Andrew Sindone will provide an update on heart failure in primary care. Earn up to 4 hours CPD. RACGP & ACRRM accredited.
Clinical Articles
